Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
about
Immunodeficiency associated with anorexia nervosa is secondary and improves after refeedingTranscriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells: evidence for involvement of C/EBP betaCytokines and the anorexia of infection: potential mechanisms and treatments.Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemiaInterleukin-1-induced anorexia in the rat. Influence of prostaglandins.Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionMonoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states.A proinflammatory mediator with potential relevance in aging.Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexiaFever and acute phase response induced in dwarf goats by endotoxin and bovine and human recombinant tumour necrosis factor alpha.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Lipid metabolism during the initiation of lactation in the rat. The effects of starvation and tumour growth.Tumour necrosis factor alpha (cachectin) mimics some of the effects of tumour growth on the disposal of a [14C]lipid load in virgin, lactating and litter-removed rats.Interleukin-1 and lipid metabolism in the rat.Comparative effects of tumour necrosis factor-alpha (cachectin), interleukin-1-beta and tumour growth on amino acid metabolism in the rat in vivo. Absorption and tissue uptake of alpha-amino[1-14C]isobutyrate.Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo.In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours.Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis.Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms.LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex.Nutrition and cytokine action.
P2860
Q24538338-0B9D4781-86DC-40AA-AB46-FC35F05B4E7CQ28198760-AA23760B-54C8-4137-BBDA-D43273E3D029Q34170497-A3056ECC-6238-40F8-9B63-718CBC2A5DA5Q34224994-642A7FD9-3F63-4CF5-8A15-66CCAFCF0B7DQ34569886-3E2180FA-0123-4AC5-8152-E0803084209EQ34577256-3C4A58DA-14A9-4F99-896B-10A2D0051560Q35809927-80976771-CA65-4025-B763-E8D13DC1E4E7Q35833307-23AA785A-50EF-4134-8E84-32DC2B284E65Q36227233-0D88B971-74B4-40D0-89C1-24B6B54454C9Q36231736-40CBA7CF-33CE-4213-A083-9CA1D2092BD8Q36363681-F7B17E9D-0B43-4A06-8B6C-BFFC0D2040C4Q36548743-420421ED-68DB-4C64-A2E5-9FF415906643Q36927535-AD57BDF9-39BE-42A4-AAB7-EEC55EAEB7B7Q37962343-59186859-21DA-4D14-9F41-E9ED8739E598Q40511940-70D1BD29-FB40-4019-9A27-213B944DCA94Q40725816-11E9836C-AB80-43D0-B4DA-A4CA5BD4C10CQ41146515-44139198-AF71-4B81-A88F-D028634DB153Q42570679-A5E2BAD5-5422-445F-B187-7329D377C4F1Q42820996-B2C2B578-A545-4BDE-8CDD-2EB1A7BA8CDDQ42836099-957DBA6A-EFDD-494F-B5A9-990D060E5B02Q42836587-621E89AA-4ADD-4FD0-A06F-DD74EAFC6D07Q42980655-CD5ABBF1-BCE6-4402-82C8-28DC2E42377EQ43051041-9794AA5B-A114-4547-84C0-64C21BB16D0DQ46046494-443B4DFB-0D61-440A-ADB4-EB7FB942DEEAQ46500048-7D8A8F00-9166-46FD-A477-26FCF46F2D9BQ47134033-320D4B76-61F9-4ED9-9194-802F3BFA4335Q48510623-D37C6EA7-C6C0-423C-A141-662EA1F49420Q53808732-C83708F4-3816-4AC8-8816-E58FA744DBD3
P2860
Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Development of partial toleran ...... rosis factor-alpha in rodents.
@ast
Development of partial toleran ...... rosis factor-alpha in rodents.
@en
type
label
Development of partial toleran ...... rosis factor-alpha in rodents.
@ast
Development of partial toleran ...... rosis factor-alpha in rodents.
@en
prefLabel
Development of partial toleran ...... rosis factor-alpha in rodents.
@ast
Development of partial toleran ...... rosis factor-alpha in rodents.
@en
P2093
P2860
P356
P1476
Development of partial toleran ...... rosis factor-alpha in rodents.
@en
P2093
P2860
P304
P356
10.1172/JCI113245
P407
P577
1987-12-01T00:00:00Z